Related references
Note: Only part of the references are listed.Differential expression of VEGF ligands and receptors in prostate cancer
David J. Woollard et al.
PROSTATE (2013)
Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
Aditi Gupta et al.
MOLECULAR CANCER (2012)
Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells
Yingyi Wang et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
Reason Wilken et al.
MOLECULAR CANCER (2011)
Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells
Brian W. Robertson et al.
MOLECULAR CANCER (2010)
Osteoclast-Derived Matrix Metalloproteinase-9 Directly Affects Angiogenesis in the Prostate Tumor-Bone Microenvironment
Alexandre Bruni-Cardoso et al.
MOLECULAR CANCER RESEARCH (2010)
Tissue Factor and VEGF Expression in Prostate Carcinoma: A Tissue Microarray Study
Jorge L. Yao et al.
CANCER INVESTIGATION (2009)
Acetyl-11-Keto-β-Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
Xiufeng Pang et al.
CANCER RESEARCH (2009)
Characterization of the Expression of Variant and Standard CD44 in Prostate Cancer Cells: Identification of the Possible Molecular Mechanism of CD44/MMP9 Complex Formation on the Cell Surface
B. Desai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells
J. Dai et al.
ONCOGENE (2009)
The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
E. S. Rennel et al.
BRITISH JOURNAL OF CANCER (2008)
Curcumin and cancer: An old-age disease with an age-old solution
Preetha Anand et al.
CANCER LETTERS (2008)
Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition
D. G. Binion et al.
GUT (2008)
Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion
Bhavik Desai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway
Yvonne G. Lin et al.
CLINICAL CANCER RESEARCH (2007)
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Bhavik Desai et al.
MOLECULAR CANCER (2007)
The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis
Goutam Chakraborty et al.
CURRENT MOLECULAR MEDICINE (2006)
The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo
J. H. Hong et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Increased expression of osteopontin contributes to the progression of prostate cancer
AC Khodavirdi et al.
CANCER RESEARCH (2006)
Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer
S Swarnakar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface
E Mira et al.
JOURNAL OF CELL SCIENCE (2004)
Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model
E Menu et al.
BRITISH JOURNAL OF CANCER (2004)
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis
N Giuliani et al.
LEUKEMIA (2004)
Roles of main pro-and anti-angiogenic factors in tumor angiogenesis
Zhi Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis
M Gattorno et al.
RHEUMATOLOGY (2004)
Matrix metalloproteinase-2: Mechanism and regulation of NF-kappa B-mediated activation and its role in cell motility and ECM-invasion
S Philip et al.
GLYCOCONJUGATE JOURNAL (2004)
Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions
SM Kumta et al.
LIFE SCIENCES (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Osteopontin and colon cancer progression
TJ Yeatman et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells
MM Binda et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
A Pozzi et al.
ONCOGENE (2002)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B
R Mohan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Microvasculature and VEGF expression in cartilaginous tumors
G Ayala et al.
HUMAN PATHOLOGY (2000)
Elevated matrix metalloprotease and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization
A Pozzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)